5 Dec 2018  9:00 – 10:30 am

When addressing the contractual relationships between a university and its spin-off: What are the issues regarding equity, royalties and research income? How do VCs, academic institutions, spin-off management and human resources management of the university interact? What are the main conflicts of interests that can arise from people holding dual positions, in the university and in the start-up?

They will share their experiences:

  • Adrian Ibrahim, Head of technology Transfer, Wellcome Sanger Institute (UK)
  • Caroline Barelle, CEO, Elasmogen (UK)
  • Alain Chevallier, Life Sciences Partner, Truffle Capital (FR)
  • Steven J. Klein, Vice President, Business Development IRICoR – Institute for Research in Immunology and Cancer – Commercialization of Research (CA)